GB9814620D0 - Vasculoprotector - Google Patents

Vasculoprotector

Info

Publication number
GB9814620D0
GB9814620D0 GBGB9814620.2A GB9814620A GB9814620D0 GB 9814620 D0 GB9814620 D0 GB 9814620D0 GB 9814620 A GB9814620 A GB 9814620A GB 9814620 D0 GB9814620 D0 GB 9814620D0
Authority
GB
United Kingdom
Prior art keywords
vasculoprotector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9814620.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Pharma AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB filed Critical Karo Bio AB
Priority to GBGB9814620.2A priority Critical patent/GB9814620D0/en
Publication of GB9814620D0 publication Critical patent/GB9814620D0/en
Priority to CA002331885A priority patent/CA2331885A1/en
Priority to AU46364/99A priority patent/AU4636499A/en
Priority to JP2000558117A priority patent/JP2002519435A/en
Priority to EP99929579A priority patent/EP1094806A2/en
Priority to PCT/GB1999/002157 priority patent/WO2000001716A2/en
Priority to KR1020017000141A priority patent/KR20010079495A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB9814620.2A 1998-07-06 1998-07-06 Vasculoprotector Ceased GB9814620D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9814620.2A GB9814620D0 (en) 1998-07-06 1998-07-06 Vasculoprotector
CA002331885A CA2331885A1 (en) 1998-07-06 1999-07-06 Vasculoprotector
AU46364/99A AU4636499A (en) 1998-07-06 1999-07-06 Vasculoprotector
JP2000558117A JP2002519435A (en) 1998-07-06 1999-07-06 Vascular protective agent
EP99929579A EP1094806A2 (en) 1998-07-06 1999-07-06 Vasculoprotector
PCT/GB1999/002157 WO2000001716A2 (en) 1998-07-06 1999-07-06 Vasculoprotector
KR1020017000141A KR20010079495A (en) 1998-07-06 1999-07-06 Vasculoprotector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9814620.2A GB9814620D0 (en) 1998-07-06 1998-07-06 Vasculoprotector

Publications (1)

Publication Number Publication Date
GB9814620D0 true GB9814620D0 (en) 1998-09-02

Family

ID=10835023

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9814620.2A Ceased GB9814620D0 (en) 1998-07-06 1998-07-06 Vasculoprotector

Country Status (7)

Country Link
EP (1) EP1094806A2 (en)
JP (1) JP2002519435A (en)
KR (1) KR20010079495A (en)
AU (1) AU4636499A (en)
CA (1) CA2331885A1 (en)
GB (1) GB9814620D0 (en)
WO (1) WO2000001716A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000016759A2 (en) * 1998-09-17 2000-03-30 Guido Schnyder Genistein for the treatment of coronary heart disease and for the prevention of restenosis after percutaneous transluminal coronary angioplasty
JP2004515496A (en) * 2000-12-07 2004-05-27 アストラゼネカ・アクチエボラーグ Benzimidazole therapeutic agent
UA83620C2 (en) 2001-12-05 2008-08-11 Уайт Substituted benzoxazoles and analogues as estrogenic agents
US6835745B2 (en) 2002-01-15 2004-12-28 Wyeth Phenyl substituted thiophenes as estrogenic agents
US7674783B2 (en) 2002-11-22 2010-03-09 Dimera Inc. Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease
CA2578164A1 (en) 2004-09-07 2006-03-16 Wyeth 6h-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents
JP2008174463A (en) * 2007-01-16 2008-07-31 Ankhs:Kk TGF-beta SIGNAL TRANSMISSION MECHANISM INHIBITOR, SMAD DEGRADATION INDUCTOR, SMAD UBIQUITIN FORMATION PROMOTER, SMURF DEGRADATION INDUCTOR, SMURF UBIQUITIN FORMATION PROMOTER, METHOD FOR INHIBITING TGF-beta SIGNAL TRANSMISSION MECHANISM, METHOD FOR INDUCING SMAD DEGRADATION, METHOD FOR PROMOTING SMAD UBIQUITIN FORMATION, METHOD FOR INDUCING SMURF DEGRADATION, AND METHOD FOR PROMOTING SMURF UBIQUITIN FORMATION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05317408A (en) * 1992-05-20 1993-12-03 Nippon Sherwood Kk Artificial blood vessel
JP3476604B2 (en) * 1995-08-22 2003-12-10 鐘淵化学工業株式会社 Method for manufacturing stent with drug attached / coated
US5958710A (en) * 1995-09-08 1999-09-28 Karo Bio Ab Orphan receptor
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP2829388B2 (en) * 1996-09-27 1998-11-25 農林水産省四国農業試験場長 Composition for promoting cell differentiation into fat cells
JPH11139974A (en) * 1997-11-07 1999-05-25 Kureha Chem Ind Co Ltd Tissue fibrosis suppressant
US5919813C1 (en) * 1998-03-13 2002-01-29 Univ Johns Hopkins Med Use of a protein tyrosine kinase pathway inhibitor in the treatment of diabetic retinopathy

Also Published As

Publication number Publication date
EP1094806A2 (en) 2001-05-02
KR20010079495A (en) 2001-08-22
CA2331885A1 (en) 2000-01-13
WO2000001716A2 (en) 2000-01-13
AU4636499A (en) 2000-01-24
JP2002519435A (en) 2002-07-02
WO2000001716A3 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
GB2339200B (en) Genostics
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
GB0116362D0 (en) Ammumition
DE69943409D1 (en) Fmcw-radar
EA199900308A3 (en) Swichgear
DE69914921D1 (en) Phenyl-xanthinderivate
DE69940558D1 (en) Fluoromonomerpolymerisation
DE69835235D1 (en) Thermoplastische silikonelastomere
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
DE69908871D1 (en) Thermisch härtbare glasplatte
DE69934603D1 (en) Elektrophotographischer photoconduktor
DE69915628D1 (en) Ritonavir-polymorph
DE60042897D1 (en) Photovervielfacherröhre
DE69939823D1 (en) Endo-beta-n-acetylglukosaminidase
DE69938146D1 (en) Ptc-chip-thermistor
DE69904442D1 (en) Cyclohexandiol-derivate
DE69905001D1 (en) Koagulationsvorrichtung
DE59904407D1 (en) Chromanderivate
DE69925859D1 (en) Cycloalkylsubstituierte aminomethylpyrrolidin-derivate
EP1059091A4 (en) Transmucous sorbefacients

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)